InvestorsHub Logo
Followers 5
Posts 459
Boards Moderated 0
Alias Born 03/05/2004

Re: lumpina post# 1717

Tuesday, 07/04/2017 6:40:13 AM

Tuesday, July 04, 2017 6:40:13 AM

Post# of 2537
It's going to come down to one day, just one day, and one day only! Thursday, August 10, 2017.

The FDA's advisory committee's decision day. Does DVAX get approval for its hepatitis B vaccine “Heplisav-B” on their third try?

That's make-it or break-it day!

On that day, DVAX price per share either rises $8.00 or drops $8.00.

This is just my opinion! Do your own "due diligence".

P.S. In the mean time, watch Friday, July 28, 2017. Biologics License Application (BLA),VRBPAC (FDA) review meeting with DVAX.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DVAX News